Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

KRX/000020 stock hub

KRX/000020 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KRX/000020is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

162.7B

Korea Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

KRX/000020

In the news

Latest news · KRX/000020

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 9.8P50 17.1P75 31.9

Trailing P/E18.8

P25 12P50 23.1P75 39.5

ROE1

P25 -17.1P50 0.7P75 8.5

ROIC-0

P25 -9P50 1.3P75 6.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KRX/000020 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

231

Groups with data

Currency

KRW

Showing 231 of 231 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Employees	826
Employees Change	33%
Employees Change Percent	4.16
Enterprise value	KRW 283.4B
Exchange	Korea Stock Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	KR7000020008
Last refreshed	2026-05-10
Market cap	KRW 162.7B
Price	KRW 5,870
Price currency	KRW
Rev Per Employee	600,961,634.1x
Sector	Healthcare
Sic	2834
Symbol	krx/000020
Website	https://www.dong-wha.co.kr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.34%
EV Earnings	32.63x
EV/EBITDA	13.05x
EV/FCF	-7.37x
EV/Sales	0.57x
FCF yield	-23.63%
P/B ratio	0.41x
P/E ratio	18.75x
P/S ratio	0.33x
PE Ratio10 Y	25.03x
PE Ratio3 Y	22.02x
PE Ratio5 Y	19.86x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-0.05%
EBITDA Margin	4.38%
Gross margin	44.03%
Gross Profit	KRW 218.5B
Gross Profit Growth	2%
Gross Profit Growth Q	-4.98%
Gross Profit Growth3 Y	6.49%
Gross Profit Growth5 Y	9.53%
Net Income	KRW 8.7B
Net Income Growth	56.13%
Net Income Growth Quarters	3%
Net Income Growth Years	1%
Net Income Growth3 Y	-24.75%
Net Income Growth5 Y	-21.16%
Pretax Margin	1.21%
Profit Margin	1.75%
Profit Per Employee	KRW 10.5M
Profitable Years	20
ROA	-0.02
Roa5y	2.2
ROCE	-0.06
ROE	0.96
Roe5y	4.01
ROIC	-0.03
Roic5y	4.55

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-2.33%
Cagr15y	2.74%
Cagr1y	-5.64%
Cagr20y	1.89%
Cagr3y	-10.23%
Cagr5y	-15.45%
Div CAGR10	-5.12%
Div CAGR3	-28.79%
Div CAGR5	-18.43%
EPS Growth	55.72
EPS Growth Quarters	3
EPS Growth Years	1
EPS Growth3 Y	-24.81
EPS Growth5 Y	-21.24
OCF Growth10 Y	-3.67%
OCF Growth3 Y	-18.71%
OCF Growth5 Y	-21.37%
Revenue Growth	6.78x
Revenue Growth Q	2.54x
Revenue Growth Quarters	8x
Revenue Growth Years	5x
Revenue Growth3 Y	13.4x
Revenue Growth5 Y	12.78x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.79
Assets	KRW 642.2B
Cash	KRW 24.4B
Current Assets	KRW 217.6B
Current Liabilities	KRW 202.8B
Debt	KRW 123.2B
Debt EBITDA	KRW 5.67
Debt Equity	KRW 0.31
Debt FCF	KRW -3.2
Equity	KRW 401.4B
Interest Coverage	-0.05
Liabilities	KRW 240.7B
Long Term Assets	KRW 424.6B
Long Term Liabilities	KRW 37.9B
Net Cash	KRW -98.8B
Net Cash By Market Cap	KRW -60.74
Net Debt EBITDA	KRW 4.55
Net Debt Equity	KRW 0.25
Tangible Book Value	KRW 297.4B
Tangible Book Value Per Share	KRW 10,680
WACC	4.52

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.07
Inventory Turnover	2.97
Net Working Capital	KRW 87.3B
Quick ratio	0.57
Working Capital	KRW 14.8B
Working Capital Turnover	KRW 8.29

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.26%
Dividend Growth	-63.89%
Dividend Growth Years	0%
Dividend per share	KRW 180
Dividend Years	1
Dividend Yield	3.07%
Ex Div Date	2026-03-24
Last Dividend	KRW 65
Payout Frequency	Annual
Payout Ratio	57.44%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-20.96%
1Y total return	-5.64%
200-day SMA	6,246.4
3Y total return	-27.67%
50-day SMA	5,998
50-day SMA vs 200-day SMA	50under200
5Y total return	-56.78%
All Time High	34,450
All Time High Change	-82.96%
All Time High Date	2020-08-11
All Time Low	1,092
All Time Low Change	437.55%
All Time Low Date	1998-01-05
ATR	112.5
Beta	0.35
Beta1y	0.14
Beta2y	0.25
Ch YTD	-6.08
High	5,960
High52	7,140
High52 Date	2025-07-11
High52ch	-17.79%
Low	5,840
Low52	5,560
Low52 Date	2026-01-21
Low52ch	5.58%
Ma50ch	-2.13%
Price vs 200-day SMA	-6.03%
RSI	41.22
RSI Monthly	35.05
RSI Weekly	41.26
Sharpe ratio	-0.27x
Sortino ratio	-0.12
Total Return	2.8%
Tr YTD	-5.03
Tr15y	50.09%
Tr1m	2.27%
Tr1w	-2.17%
Tr3m	-2.7%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW -243.2M
Operating margin	-0.05

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	18,289,147%
Net Borrowing	19,357,656,500
Shares Insiders	13.34%
Shares Institutions	8.05%
Shares Out	27,717,930
Shares Qo Q	0.48%
Shares Yo Y	0.26%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW -38.4B
Average Volume	73,724.95x
Bv Per Share	13,627.5
CAPEX	KRW -54.1B
Ch10y	-32.53
Ch15y	18.59
Ch1m	2.27
Ch1w	-2.17
Ch1y	-6.68
Ch20y	5.2
Ch3m	-3.77
Ch3y	-31.74
Ch5y	-60.47
Ch6m	-3.93
Change	-0.51%
Change From Open	-0.34
Close	5,900
Days Gap	-0.17
Depreciation Amortization	21,965,349,670
Dollar Volume	283,497,520
Earnings Date	2026-03-30
EBIT	KRW -243.2M
EBITDA	KRW 21.7B
EPS	KRW 313
F Score	4
FCF	KRW -38.4B
FCF EV Yield	-13.56x
FCF Per Share	KRW -1,387
Financing CF	13,398,935,690
Fiscal Year End	December
Founded	1,897
Goodwill	24,930,531,000
Graham Number	9796.50545
Graham Upside	66.89
Income Tax	KRW 2.2B
Investing CF	-41,180,106,750
Is Primary Listing	1
Last Earnings Date	2026-02-20
Last Report Date	2025-12-31
Last Split Date	2009-06-30
Last Split Type	Forward
Lynch Fair Value	KRW 1,565
Lynch Upside	-73.34
Ma150	6,150.9
Ma150ch	-4.57%
Ma20	5,974.5
Ma20ch	-1.75%
Net CF	-12,351,012,980
Open	5,890
P OCF Ratio	10.36
Payment Date	2026-04-24
Position In Range	25
Ppne	210,056,183,530
Price Date	2026-05-08
Price EBITDA	KRW 7.49
Ptbv Ratio	0.55
Relative Volume	0.65x
Revenue	496,394,309,770x
SBC By Revenue	0x
Share Based Comp	4,947,420
Tax By Revenue	0.44x
Tax Rate	35.99%
Tr20y	45.27%
Tr6m	-2.86%
Volume	48,296
Z Score	1.89

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

KRX/000020 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.1%

$180 annual per share

Payout ratio

+57.4%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-18.4%

0 consecutive years of growth

Total shareholder yield

+2.8%

Next ex-dividend date: 2026-03-24

Performance

KRX/000020 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KRX/000020?

Insider, institutional, and short-interest positioning.

Institutional ownership

+8.0%

Share of float held by funds and institutions

Insider ownership

+13.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.3%

Negative means the company is buying back shares.

Technical

KRX/000020 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

41.2

Neutral momentum band

Price vs 200-day MA

-6.0%

50/200-day relationship not available

Beta (5Y)

0.35

Less volatile than the market

Sharpe ratio

-0.27

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KRX/000020

Hub-level FAQ points readers to the deeper analysis pages.

What is the current krx/000020 stock rating?

krx/000020 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full krx/000020 analysis?

The full report lives at /stocks/krx/000020/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for krx/000020?

The latest report frames krx/000020 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the krx/000020 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.